Sustained release of drug loaded within biotinylated perfluorocarbon nanoparticles and use in magnetic resonance imaging

ZHOU Zhao-xiong,ZHANG Bai-gen,ZHANG Hao,SUN Li,WANG Xiao-min,ZHANG Ji-wei
2009-01-01
Abstract:AIM To investigate the in vitro release profile of loading drugs encapsulated within the perfluorocarbon(PFC) nanoparticles(NPs) and its ability of enhancing magnetic resonance imaging(MRI).METHODS Dexamethasone sodium phosphate(DxP) or dexamethasone acetate(DxA),and gadopentetate dimeglumine(Gd-DTPA) loaded within biotinylated PFC NPs were constructed by high pressure homogeneous processing method.The morphology and size of NPs were examined by scanning electron microscope(SEM) and laser particle size analyzer.Drug loading and in vitro releasing were assessed by high performance liquid chromatography(HPLC).MRI was used to observe the imaging and signal intensity of contrast within the NPs.RESULTS The particle size of DxP-NP and DxA-NP were(224 ± s 6) and(236 ± 9) nm,respectively.The encapsulation efficiency(EE) of DxP-NP were(66.4 ± 1.0) %,with an obviously bursting phenomenon,the initial releasing rate were 77.2%,while the EE of DxA-NP were(95.3 ± 1.3) %,the initial releasing were 23.6%.Both of the two NPs could release persisted over one week.The NPs loading Gd-DTPA could enhance the signal intensity of Gd-DTPA about 16% detected by MRI.CONCLUSION PFC NPs loaded with hydrophilic drug have relatively high encapsulation efficiency and sustained release pattern.Contrast loaded within NPs could enhance the signal intensity detected by MRI.
What problem does this paper attempt to address?